Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Advocates for Youth

InstitutionResearch output, impact & collaborations

Advocates for Youth is a institution indexed in PICO Portal from OpenAlex.

What is known about Advocates for Youth?

PICO Portalrecord summary

Advocates for Youth is a research organisation in Washington D.C., US. OpenAlex records 1,401 works and 20,770 citations for it. 511 researchers list it as their most recent affiliation.

How many works does Advocates for Youth have?

PICO Portalindexed works

Advocates for Youth has 1,401 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Advocates for Youth have?

PICO Portalcitation count

Advocates for Youth has 20,770 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Advocates for Youth?

PICO Portalresearcher count

Advocates for Youth has 511 researchers in the PICO Portal index.

What is the average h-index at Advocates for Youth?

PICO Portalavg h-index

Advocates for Youth has an average h-index of 84 in OpenAlex.

What is the ROR of Advocates for Youth?

PICO Portalror

The ROR for Advocates for Youth is on the source record.

What is the OpenAlex record for Advocates for Youth?

PICO Portalopenalex

The OpenAlex for Advocates for Youth is on the source record.

What is the Wikidata of Advocates for Youth?

PICO Portalwikidata

The Wikidata for Advocates for Youth is on the source record.

Who are the most-cited researchers behind Advocates for Youth?

PICO Portaltop researchers by citations
1
Joan H. Schiller · Lung Cancer Treatments and Mutations
521 works43,297 citations

What are the most-cited papers on Advocates for Youth?

PICO Portalmost cited works
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson
New England Journal of Medicine. 20065,784 CitationsOPEN ACCESS
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay
JAMA. 20032,541 Citations
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn
JAMA. 20141,758 Citations
Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis
Andrea Ardizzoni, Luca Boni, Marcello Tiseo, Frank V. Fossella, Joan H. Schiller, Marianne Paesmans, Davorin Radosavljević, Adriano Paccagnella, Petr Zatloukal, Paola Mazzanti, D. Bisset, R. Rosell
JNCI Journal of the National Cancer Institute. 2007609 CitationsOPEN ACCESS
Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study
Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer, Ming‐Sound Tsao, Gregory A. Masters, James R. Jett, Martin J. Edelman, Rogério Lilenbaum, Hak Choy, Fadlo R. Khuri, Katherine M.W. Pisters, David R. Gandara, Kemp H. Kernstine, Charles Butts, Jonathan Noble, Thomas A. Hensing, Kendrith M. Rowland, Joan H. Schiller, Keyue Ding, Frances A. Shepherd
Journal of Clinical Oncology. 2013366 CitationsOPEN ACCESS

How much of the research on Advocates for Youth is open access?

PICO Portalopen access share
60%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
60%
Closed
40%

Related on PICO Portal

470M+ articles · 14-day free trial